The possibilities of computer tomography in the quantitative assessment of lung injury in SARS-COV-2 pneumonia

2023

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.59598/me-2305-6045-2023-108-3-16-23
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The aim of the study: to evaluate the effect of the degree of lung injury on the disease progression in COVID-19. Materials and methods: during the study, 100 patients were examined on the basis of the coronavirus hospital of the Non-commercial JSC «Karaganda medical university» (Karaganda city) among the ages from 18 to 93 years. All patients underwent computed tomography (CT) on Canon Aquilion Prime SP tomograph (160 sections). Scanning was carried out at admission, on 4-5, 8-9 days or according to indications. The degree of lung injury in CT was determined on the basis of an «empirical» percentage visual scale of CT 0-4. A comparative assessment of changes in lung tissue with the stages of the course of the disease SARS-COV-2 was carried out. Results and discussion: when comparing the indicators of the degree of lung damage in CT and the clinical severity of the disease, they have a weak direct correlation (P≥0.05). Conclusion: CT is a highly informative diagnostic method of SARS-COV-2 (sensitivity 97-98 %), allows to identify all semiotic elements of lung tissue injury, the extent of the pathological process, the effectiveness of the treatment and prediction of the clinical course of the disease.